NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 2 filers reported holding NPS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $7,998,000 | +8.5% | 223,600 | -21.2% | 0.16% | +17.9% |
| Q3 2014 | $7,374,000 | -24.0% | 283,600 | -3.4% | 0.14% | -18.1% |
| Q2 2014 | $9,703,000 | +14.3% | 293,600 | +3.5% | 0.17% | +17.1% |
| Q1 2014 | $8,488,000 | -7.9% | 283,600 | -6.6% | 0.15% | -8.8% |
| Q4 2013 | $9,217,000 | +15.9% | 303,600 | +21.4% | 0.16% | +17.6% |
| Q3 2013 | $7,953,000 | +75.4% | 250,000 | -16.7% | 0.14% | +74.4% |
| Q2 2013 | $4,533,000 | – | 300,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 424,175 | $12,695,000 | 5.06% |
| Opaleye Management Inc. | 150,000 | $4,490,000 | 3.32% |
| OAK RIDGE INVESTMENTS LLC | 2,795,331 | $83,664,000 | 2.10% |
| SCHOLTZ & COMPANY, LLC | 60,350 | $1,806,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 1,408,729 | $42,163,000 | 1.73% |
| First Light Asset Management, LLC | 79,099 | $2,367,000 | 1.68% |
| FCG ADVISORS, LLC | 71,146 | $2,129,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 166,970 | $4,997,000 | 1.50% |
| BENDER ROBERT & ASSOCIATES | 73,611 | $2,203,000 | 1.48% |
| Eventide Asset Management | 283,900 | $8,497,000 | 1.32% |